| 000 | 00560nam a22001817a 4500 | ||
|---|---|---|---|
| 999 |
_c429 _d429 |
||
| 003 | SUN | ||
| 005 | 20180714113122.0 | ||
| 008 | 180714b ug ||||| |||| 00| 0 eng d | ||
| 020 | _a9780786445424 | ||
| 040 | _cSUNLIB | ||
| 082 |
_a616.4624 _bKAG |
||
| 100 |
_aKagan Andrew _9750 |
||
| 110 |
_aAndrew Kagan _9751 |
||
| 245 |
_aType 2 diabetes _bSocial and scientific origins, medical complications and implications for patients and others _cAndrew Kagan |
||
| 260 |
_aLondon _bMcfarland and company, Inc _c2010 |
||
| 300 |
_aX, 228p. _bill. _c23cm. |
||
| 942 |
_2ddc _cBK |
||